Abstract
Three studies reveal that the presence in tumours of two key immune components — B cells and tertiary lymphoid structures — is associated with favourable outcomes when individuals undergo immunotherapy. B cells are associated with favourable responses to immunotherapy.

This publication has 15 references indexed in Scilit: